Article metrics
PDF
Other content recommended for you
- Factors, enablers and challenges for COVID-19 vaccine development
- US public investment in development of mRNA covid-19 vaccines: retrospective cohort study
- Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries
- Comparing research and development, launch, and scale up timelines of 18 vaccines: lessons learnt from COVID-19 and implications for other infectious diseases
- The case for adopting a combined comparative medicine and One Health approach to tackle emerging diseases
- Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?
- Evolving pharmacovigilance requirements with novel vaccines and vaccine components
- Healthcare provider perspectives on COVID-19 vaccination for children in India
- Vaccine nationalism and internationalism: perspectives of COVID-19 vaccine trial participants in the United Kingdom
- Future of covid-19 vaccine pricing: lessons from influenza